Compare Heron Therapeutics Inc (HRTX) vs Lowe`s Companies Inc (LOW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Heron Therapeutics Inc vs Lowe`s Companies Inc — how do they compare? Heron Therapeutics Inc trades at $0.37 (market cap $74.04M), while Lowe`s Companies Inc trades at $189 (market cap $101.85B). The key difference: Lowe`s Companies Inc is far larger — about 1375.6× Heron Therapeutics Inc's market cap, and Lowe`s Companies Inc pays a 2.75% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Heron Therapeutics Inc for 35 Days and Lowe`s Companies Inc for 98 Days on average.
| HRTX | LOW | |
|---|---|---|
Market Cap | $74.04M | $101.85B |
Volume | 3,668,095 | 2,370,093 |
Sector | Health | Consumer Cyclical |
52-Week High | $1.49 | $287.39 |
52-Week Low | $0.27 | $179.50 |
Typical Hold Time | 35 Days | 98 Days |
Enterprise Value | $180.78M | $140.70B |
Dividend Yield | — | 2.75% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HRTX trades at $0.39, up 17.58% today, with a bullish technical signal from moving averages. The company reported Q2 2026 revenue of $37.7 million but missed EPS estimates with a $0.03 loss. Despite negative profitability metrics, analyst consensus remains strongly positive with 89% buy ratings. Recent news highlights ongoing comparisons with peers and earnings performance discussions.
The outlook is mixed: strong analyst support and technical momentum suggest potential upside, but persistent losses and high valuation ratios pose significant risks. Investment opportunity hinges on revenue growth translating to profitability, while key risks include execution challenges and competitive pressures in the biotechnology sector.
Lowe's Companies (LOW) trades at $188.85, up 2.81% on the day, with a bearish technical signal but strong analyst support. The stock has beaten earnings estimates for three consecutive quarters, with Q3 2026 results pending. Revenue declined to $83.67 billion in 2025, though net income margin remains healthy at 7.35%. Recent news highlights drone delivery innovation with DoorDash and Alphabet, aiming to enhance customer convenience amid a challenging home improvement market.
The outlook is mixed: analyst consensus is bullish with a $244.09 price target, but technical indicators and industry headwinds pose risks. Investment opportunity lies in valuation metrics like a P/E of 15.35 and dividend consistency, while risks include high debt levels and sensitivity to housing market trends. Earnings performance and execution of new initiatives will be critical for stock appreciation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →About Lowe`s Companies Inc
Lowe's is the second-largest home improvement retailer in the world, operating 1,969 stores and servicing around 230 dealer-owned stores throughout the United States and Canada. The firm's stores offer products and services for home decorating, maintenance, repair, and remodeling, with maintenance and repair accounting for two thirds of products sold. Lowe's targets retail do-it-yourself (around 75% of sales) and do-it-for-me customers as well as commercial and professional business clients (around 25% of sales). We estimate Lowe's captures a low-double-digit share of the domestic home improvement market, based on U.S. Census data and management's estimates for market size.
Read more on LOW →
